INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹0.11 Cr | ₹1.36 Cr | ₹4.24 Cr | ₹36 Cr | ₹40 Cr |
What is the latest Contingent Liabilities ratio of INDSWIFT LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹0.11 Cr |
| Mar2024 | ₹1.36 Cr |
| Mar2023 | ₹4.24 Cr |
| Mar2022 | ₹36 Cr |
| Mar2021 | ₹40 Cr |
How is Contingent Liabilities of INDSWIFT LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.11 Cr | -91.59 | |
| Mar2024 | ₹1.36 Cr | -68.05 | |
| Mar2023 | ₹4.24 Cr | -88.11 | |
| Mar2022 | ₹36 Cr | -11.00 | |
| Mar2021 | ₹40 Cr | - | |
Compare Contingent Liabilities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹3,170.3 Cr | -2.7% | 24.3% | 258.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -2.5% | -4.7% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,223.0 Cr | -4% | 8.1% | 55.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹183,453.0 Cr | -2.3% | 0.2% | 36.6% | Stock Analytics | |
| CIPLA | ₹109,849.0 Cr | -1.7% | -6.1% | -12% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,591.8 Cr | -0.2% | -4.4% | -10.2% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | -2.7% |
24.3% |
258.9% |
| SENSEX | -1.6% |
-4.7% |
-8.3% |
You may also like the below Video Courses